Trials / Completed
CompletedNCT02355639
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
A Single-Centre, Explorative, Randomised, Investigator-Blinded, Negative-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess Steroid Induced Skin Atrophy on Healthy Skin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- Male
- Age
- 25 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess steroid induced skin atrophy by sonography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clobetasol propionate 0.05 % ointment | |
| DRUG | Betamethasone dipropionate 0.064 % ointment | |
| DRUG | Petrolatum ointment |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-02-04
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02355639. Inclusion in this directory is not an endorsement.